WHO declares PH Dengue vaccine safe
A few weeks ago, the WHO cautioned the country to be wary with the distribution of the new dengue vaccines, as the World Health Organization has yet to complete stringent testing measures to ensure the safety and efficiency of the vaccine. Now, the WHO has given the green light to the vaccine the Philippines is administering and has declared it safe.
READ ALSO: DOH: dengue vaccine distribution was ‘hasty’
The Department of Health was confident it was correct in its assessment after a panel expert from the World Health Organization recommended the administration of the vaccine in the country.
"This only proves that our country is on the right track in its incessant combat against dengue," said health secretary Janette Garin.
In an earlier report, there were doubts on the safety of the drug Dengavaxia. The drug is manufactured by French pharmaceutical Sanofi. It has arrived in the Philippines last February and is set to be administered to 1 million children in 3 regions which has the highest incidence of dengue cases.
"The number one main recommendation is that this vaccine is efficacious and safe but should be only used in populations where the disease incidence in the population is at least 50%," said WHO chair of the Strategic Advisory Group of Experts (SAGE) John Abramson.
WHO SAGE said that the dengue vaccine is not recommended for use in children under 9 years old, and should be given in 3 doses at a 6-month interval. It also recommended that each country define the target age for routine vaccination.
The administration of vaccines began last April 4 in regions III, IV-A, and the National Capital Region. The total grade 4 students immunized are now at 148,431 out of the 206, 673.
The first dose will be administered this April to June, the second dose on October to December, the last dose April to June 2017.